(Press-News.org) Irvine, Calif., Jan. 25, 2021 -- Scientists at the University of California, Irvine and NASA's Jet Propulsion Laboratory have for the first time quantified how warming coastal waters are impacting individual glaciers in Greenland's fjords. Their work is the subject of a study published recently in Science Advances.
Working under the auspices of the Oceans Melting Greenland mission for the past five years, the researchers used ships and aircraft to survey 226 glaciers in all sectors of one of Earth's largest islands. They found that 74 glaciers situated in deep, steep-walled valleys accounted for nearly half of Greenland's total ice loss between 1992 and 2017.
Such fjord-bound glaciers were discovered to be the most subject to undercutting, a process by which warm, salty water at the bottom of the canyons melts the ice from below, causing the masses to break apart more quickly than usual. In contrast, the team found that 51 glaciers positioned in shallower gullies experienced less undercutting and contributed only about 15 percent of the total ice loss.
"I was surprised by how lopsided it was. The biggest and deepest glaciers are undercut much faster than the smaller glaciers in shallow fjords," said lead author Michael Wood, a post-doctorate researcher at NASA's Jet Propulsion Laboratory in Southern California, who began this research as a doctoral student at UCI. "In other words, the biggest glaciers are the most sensitive to the warming waters and those are the ones really driving Greenland's ice loss."
The study highlighted the dynamic whereby deeper fjords allow the intrusion of warmer ocean water than shallow ones, hastening the process of undercutting with some of Greenland's largest glaciers.
Greenland is home to one of Earth's only two ice sheets, the largest being Antarctica's. The ice in Greenland is more than two miles (three kilometers) thick in places. At the edges of the land mass, the vast glaciers extending from the ice sheet travel slowly down valleys like icy conveyor belts, which inch into the fjords and then melt or break off as icebergs. The ice is replenished by snowfall that is compressed over time into the ice pack.
If the ice sheet were in balance, the amount of snow accumulating on the top would roughly equal the ice lost from melt, evaporation and calving - chunks breaking free from anchored masses and floating off into the ocean.
But the ice sheet has been out of balance since the 1990s. Melt has accelerated and calving has increased, causing glaciers that extend into the sea to retreat back toward land. Together, these are resulting the ice sheet shrinkage.
According to the research team, the build-up of warm salty water at the bottom of fjords has been accelerated by increasing temperatures in the summer months, which heat the surfaces of glaciers, creating pools of meltwater. This liquid leaks through cracks in the ice to form subsurface freshwater rivers which flows into the sea where it interacts with salty water beneath fjords.
Glacier meltwater is free of salt, so it is lighter than seawater and rises to the surface as a plume, dragging up warm water and putting it in contact with the bottoms of glaciers. Fjord depth is a fairly immutable factor, but other factors such as seawater temperature and the amount of meltwater from glaciers surfaces are greatly impacted by climate warming. All three factors combine to cause accelerated deterioration of Greenland's ice sheet, the researchers said.
As the water temperature around Greenland's coastline is predicted to continue to increase in the future, these findings suggest that some climate models may underestimate glacial ice loss by at least a factor of two if they do not account for undercutting by a warm ocean.
The study also lends insight into why many of Greenland's glaciers never recovered after an abrupt ocean warming between 1998 and 2007, which caused an increase in ocean temperature by nearly 2 degrees Celsius. Although ocean warming paused between 2008 and 2017, the glaciers had already experienced such extreme undercutting in the previous decade that they continued to retreat at an accelerated rate.
"We have known for well over a decade that the warmer ocean plays a major role in the evolution of Greenland glaciers," said OMG deputy principal investigator Eric Rignot, also of JPL and UCI. "But for the first time, we have been able to quantify the undercutting effect and demonstrate its dominant impact on the glacier retreat over the past 20 years."
INFORMATION:
In addition to funding from NASA, this research received support from the National Science Foundation, the Netherlands Earth System Science Centre, the Netherlands Organization for Scientific Research and the French National Research Agency.
About the University of California, Irvine: Founded in 1965, UCI is the youngest member of the prestigious Association of American Universities. The campus has produced three Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 36,000 students and offers 222 degree programs. It's located in one of the world's safest and most economically vibrant communities and is Orange County's second-largest employer, contributing $5 billion annually to the local economy. For more on UCI, visit http://www.uci.edu.
Media access: Radio programs/stations may, for a fee, use an on-campus ISDN line to interview UCI faculty and experts, subject to availability and university approval. For more UCI news, visit news.uci.edu. Additional resources for journalists may be found at communications.uci.edu/for-journalists.
Epilepsy, a neurological disease that causes recurring seizures with a wide array of effects, impacts approximately 50 million people across the world. This condition has been recognized for a long time -- written records of epileptic symptoms date all the way back to 4000 B.C.E. But despite this long history of knowledge and treatment, the exact processes that occur in the brain during a seizure remain elusive.
Scientists have observed distinctive patterns in the electrical activity of neuron groups in healthy brains. Networks of neurons move through states of similar behavior (synchronization) and dissimilar behavior (desynchronization) ...
A new study demonstrates that antibodies generated by the novel coronavirus react to other strains of coronavirus and vice versa, according to research published today by scientists from Oregon Health & Science University.
However, antibodies generated by the SARS outbreak of 2003 had only limited effectiveness in neutralizing the SARS-CoV-2 virus. Antibodies are blood proteins that are made by the immune system to protect against infection, in this case by a coronavirus.
The study published today in the journal Cell Reports.
"Our finding has some important implications concerning immunity toward different strains of coronavirus infections, ...
Astrocytes are the most abundant type of cells within the central nervous system (CNS), but they remain poorly characterized. Researchers have long assumed that astrocytes' primary function is to provide nutrients and support for the brain's more closely scrutinized nerve cells; over the years, however, increasing evidence has shown that astrocytes can also actively promote neurodegeneration, inflammation, and neurological diseases. Now, a team led by researchers from Brigham and Women's Hospital, has shown that a specific astrocyte sub-population can do the opposite, instead serving a protective, anti-inflammatory function within the brain based on signals regulated by the bacteria that reside in ...
-Data demonstrate ADG2 binds to all known variants of SARS-CoV-2 and is not impacted by known circulating resistance mutations-
-Company expects to begin clinical studies for a half-life extended version of ADG2 for the treatment and prevention of COVID-19 in early 2021-
Waltham, MA - January 25, 2021- Adagio Therapeutics, Inc., a biotechnology company developing best-in-class antibodies to broadly neutralize coronaviruses, today published in vitro and in vivo data in Science on its lead antibody candidate, ADG2, which demonstrated similar or higher potency against SARS-CoV-2 compared to other monoclonal antibodies (mAbs) in clinical development and strong binding to all known ...
Working in preclinical models, researchers report that plitidepsin, a drug with limited clinical approval for the treatment of multiple myeloma, is more potent against SARS-CoV-2 than remdesivir, an antiviral that received FDA emergency use authorization for the treatment of COVID-19 in 2020. The results suggest plitidepsin should be further evaluated as a COVID-19 therapy, the authors say; because it targets a host protein rather than a viral protein, if treatment proves successful in humans, the SARS-CoV-2 virus won't be easily able to gain resistance ...
A new approach to mapping viral mutations that "escape" leading clinical antibodies has revealed mutations in the SARS-CoV-2 virus that allow it to evade treatments, including a single amino-acid mutation that fully escapes Regeneron's antibody cocktail. These maps, say the authors, demonstrate that prior characterization of escape mutations was incomplete. They will also help to enable immediate interpretation of the effects of the mutations cataloged by viral genomic surveillance, say the authors. Several antibodies are in use or under development as therapies to treat COVID-19. As new SARS-CoV-2 variants emerge, it ...
Researchers have engineered an antibody that neutralizes SARS-CoV-2 with a potency that "rivals" current lead SARS-CoV-2 clinical neutralizing antibodies, and that also broadly neutralizes a range of clade 1 sarbecoviruses. Their antibody, ADG-2, studied in mice, represents a "promising candidate" for the prevention and treatment of not only COVID-19, they say, but also of future respiratory diseases caused by SARS-related coronaviruses. Although two vaccines and two monoclonal antibody (mAb) therapies have been authorized for emergency use by the FDA, it is unknown whether these vaccines and treatments will provide broad protection against new emerging SARS-CoV-2 strains that originate in humans or animal reservoirs; this is partly ...
During the first wave of the COVID-19 pandemic, nearly one in four families responded that they would be unlikely to bring their child to the Emergency Department if they had an emergency condition, according to a survey from Ann & Robert H. Lurie Children's Hospital of Chicago published in the journal Academic Emergency Medicine. Greater hesitancy to seek emergency care was found in families living in under-resourced communities, those who rely on public insurance and in families who are Black, Latinx or Asian.
"We observed greater hesitancy to use the Emergency Department among more vulnerable demographic groups who historically showed high utilization of emergency care for their children," ...
Cancer is the second leading cause of death in the world. The number of deaths and incidences is increasing each year. The metal-based anticancer drugs were used clinically worldwide, but suffer from poor selectivity, serious side effects and drug resistance. Tumor-targeting drug development is the basis for precise cancer treatment.
Recently, Professor Hongke Liu of Nanjing Normal University, Professor Jing Zhao and Academician Zijian Guo of Nanjing University have made breakthrough achievements in anticancer drug development. They proposed a "bio-orthogonally catalyzed lethality" (BCL) strategy ...
Hernias are one of the most common soft tissue injuries. Hernias form when intra-abdominal content, such as a loop of the intestine, squeezes through weak, defective or injured areas of the abdominal wall.
The condition may develop serious complications, therefore hernia repair may be recommended. Repair consists of surgically implanting a prosthetic mesh to support and reinforce the damaged abdominal wall and facilitate the healing process. However, currently used mesh implants are associated with potentially adverse postsurgical complications.
"Although hernia mesh implants are mechanically strong and support abdominal tissue, making the patient feel comfortable initially, ...